Regeneron Asks F.D.A. for Emergency Approval of Drug Praised by Trump

(October 08 18:02) Nytimes.com

The drug maker said access to the treatment would be extremely limited at first, with only enough doses for 50,000 patients. Here’s the latest.

You can find the original article here